Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

    • Journal of managed care & specialty pharmacy Journal

    Papers
    Letter--The Authors Respond
    Kibum Kim,Robert J DiDomenico,Daniel R Touchette,Surrey M Walton
    Journal of managed care & specialty pharmacy（2017）SCI 4区SCI 3区
    DISCLOSURES:None of the authors of this study are involved in financial or personal relationships with agencies, institutions, or organizations that inappropriately influenced the statistical analysis plan or interpretation of the study results. DiDomenico received an honorarium ...
    Cited2Views3
    2
    3
    Download
    BibtexChatPaperRate
    Health Care Utilization and Costs Associated with Direct-Acting Antivirals for Patients with Substance Use Disorders and Chronic Hepatitis C
    Xinyi Jiang,Scott Martin Vouri,Vakaramoko Diaby,Weihsuan Lo-Ciganic,Robert Parker,Haesuk Park
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    BACKGROUND: Patients with substance use disorders (SUD) and chronic hepatitis C virus infection (HCV) have limited access to direct-acting antivirals (DAAs) due to multilevel issues related to providers (eg, concern about reinfection); patients (eg, refusal); payers (eg, prior au...
    Cited4Views7
    4
    7
    BibtexChatPaperRate
    Alignment of Diagnosis and Pharmacy Claims Data Coding of Medication Adherence among Patients with Diabetes or Hypertension
    Justin Gatwood,Kenneth C. Hohmeier,Sohul Shuvo, Dina Mikaiel,Csaba P. Kovesdy
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    BACKGROUND: ICD-10-CM codes exist that facilitate provider designation of patients as "nonadherent to therapy"; however, it is unclear whether this label accurately reflects patient behavior according to widely accepted medication adherence metrics using pharmacy claims data. OBJ...
    Cited0Views3
    0
    3
    BibtexChatPaperRate
    The Effectiveness and Value of Nadofaragene Firadenovec, Oportuzumab Monatox, and Pembrolizumab for Bcg-Unresponsive Non-Muscle-Invasive Bladder Cancer
    Molly Beinfeld,Steven J. Atlas,Daniel Touchette,Avery McKenna,David Rind,Steven D. Pearson
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    DISCLOSURES: Funding for this summary was contributed by Arnold Ventures, California Health Care Foundation, The Donaghue Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the Institute for Clinical and Economic Review (ICER), an independent organizati...
    Cited6Views6
    6
    6
    BibtexChatPaperRate
    Web-Based Patient Portal Use and Medication Overlap from VA and Private-Sector Pharmacies among Older Veterans
    Kevin T. Stroupe,Kim Nazi,Timothy P. Hogan,Linda Poggensee,Bonnie Wakefield,Rachael N. Martinez,Bella Etingen,Stephanie Shimada,Katie J. Suda,Zhiping Huo,Lishan Cao,Bridget M. Smith
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    BACKGROUND: The availability of Medicare Part D pharmacy coverage may increase veterans' options for obtaining medications outside of the Department of Veterans Affairs (VA) pharmacies. However, availability of Part D coverage raises the potential that veterans may be receiving s...
    Cited3Views16
    3
    16
    BibtexChatPaperRate
    Managing High-Priced Biologic Agents: Challenges and Potential Solutions
    Meng Li,Kai Yeung
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    DISCLOSURES: No funding was received for the writing of this commentary. The authors report no conflicts of interest.
    Cited1Views1
    1
    1
    BibtexChatPaperRate
    Evaluation of the Impact of a Clinical Pharmacist on a Specialty Neurology Clinic's Adherence to Recommended Laboratory Test Monitoring
    Sarah Darby, Pamela J. Mazyck
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    BACKGROUND: Pharmacists can have a significant effect on the specialty ambulatory care setting. Specialty medications are potentially high risk and may require frequent laboratory test monitoring to assess for therapy-associated adverse effects. Pharmacists may work under collabo...
    Cited1Views1
    1
    1
    BibtexChatPaperRate
    Letter
    Seth A Seabury
    Journal of managed care & specialty pharmacy（2016）SCI 4区SCI 3区
    Seabury reports receiving consulting fees from Precision Health Economics, a life sciences firm that provides consulting services to the pharmaceutical industry.
    Cited0Views0
    0
    0
    BibtexChatPaperRate
    Comparison of Botulinum Toxins for Treatment of Movement Disorders: Real-World Utilization and Cost Analysis in a National Medicare Population
    Rashid Kazerooni,Jonathan H. Watanabe
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    BACKGROUND: The Centers for Medicare & Medicaid Services (CMS) is the single largest payer for health care in the United States and the largest payer by spending globally. Medicare Part B, with more than 50 million beneficiaries, currently has no broad mechanisms in place for pro...
    Cited3Views3
    3
    3
    BibtexChatPaperRate
    The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma
    Jeffrey A. Tice,Jonathan D. Campbell,Patricia G. Synnott,Judith M. E. Walsh,Varun M. Kumar,Melanie Whittington, Ellie Adair,David Rind,Steven D. Pearson
    Journal of managed care & specialty pharmacy（2019）SCI 4区SCI 3区
    DISCLOSURES:Funding for this summary was contributed by the Laura and John Arnold Foundation, Blue Shield of California, and California Health Care Foundation to the Institute for Clinical and Economic Review (ICER), an independent organization that evaluates the evidence on the ...
    Cited20Views10
    20
    10
    Download
    BibtexChatPaperRate
    Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
    Nicole M. Engel-Nitz,Michael P. Johnson,Scott H. Bunner,Kellie J. Ryan
    Journal of managed care & specialty pharmacy（2020）SCI 4区SCI 3区
    BACKGROUND: Non-small cell lung cancer (NSCLC) is the most common form of lung cancer in the United States. Immunotherapies and cytotoxic chemotherapies used to treat advanced NSCLC carry a substantial risk of adverse events (AEs), but real-world data on the incidence and costs a...
    Cited11Views5
    11
    5
    Download
    BibtexChatPaperRate
    Cost-effectiveness of Intravenous Vedolizumab Vs Subcutaneous Adalimumab for Moderately to Severely Active Ulcerative Colitis
    Bob G. Schultz,Ibrahim Diakite,John A. Carter,Sonya J. Snedecor,Robin Turpin
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    BACKGROUND: The efficacy of intravenous (IV) vedolizumab vs subcutaneous (SC) adalimumab for the treatment of moderately to severely active ulcerative colitis (UC) was assessed in the VARSITY clinical trial, which demonstrated for the first time in a head-to-head clinical trial s...
    Cited5Views13
    5
    13
    BibtexChatPaperRate
    International Reference Pricing for Prescription Drugs: a Landscape Analysis
    Leah Z. Rand,Aaron S. Kesselheim
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    During the Trump administration, members of Congress and the administration proposed the introduction of international reference pricing (IRP) to Medicare in order to reduce US drug spending by benchmarking prices to those in other countries. Many other countries currently use IR...
    Cited6Views0
    6
    0
    BibtexChatPaperRate
    Performance-based Pharmacy Payment Models: Key Components and Critical Implementation Considerations for Successful Uptake and Integration
    Chloe Richard,Benjamin Y. Urick,Shweta Pathak,John Jackson,Melanie Livet
    Journal of managed care & specialty pharmacy（2021）SCI 4区SCI 3区
    BACKGROUND: In the United States, the shift towards value-based health care seeks to improve patient outcomes while reducing health care spending. Although the federal government has led the implementation of performance-based models for physicians and health care systems, commer...
    Cited7Views15
    7
    15
    BibtexChatPaperRate
    Annual Costs among Patients with Major Depressive Disorder and the Impact of Key Clinical Events
    Andrew J. Cutler,Katelyn R. Keyloun,Sara Higa,Julie Park,Machaon Bonafede,Patrick Gillard,Rakesh Jain
    Journal of managed care & specialty pharmacy（2022）SCI 4区SCI 3区
    BACKGROUND: The economic burden of major depressive disorder (MDD) is substantial and increasing; however, the impact of key clinical events (eg, hospitalization, suicide attempt/ ideation, and treatment changes) on health care resource use and costs are less established. OBJECTI...
    Cited5Views8
    5
    8
    BibtexChatPaperRate